Search alternatives:
significant level » significance level (Expand Search)
significant force » significant source (Expand Search), significant sources (Expand Search), significant concern (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
force increase » fold increase (Expand Search), percent increase (Expand Search)
significant level » significance level (Expand Search)
significant force » significant source (Expand Search), significant sources (Expand Search), significant concern (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
force increase » fold increase (Expand Search), percent increase (Expand Search)
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
Single Cell Forces after Electroporation
Published 2020“…Following rounding, a majority of analyzed cells enter an unusual and unexpected biphasic stage (stage 2) characterized by increased contractility tens of minutes post-electroporation, followed by force relaxation. …”
-
175
Single Cell Forces after Electroporation
Published 2020“…Following rounding, a majority of analyzed cells enter an unusual and unexpected biphasic stage (stage 2) characterized by increased contractility tens of minutes post-electroporation, followed by force relaxation. …”
-
176
Decreased brain-derived neurotrophic factor plasma levels in psoriasis patients
Published 2019“…After adjusting for clinical and demographic variables, significantly decreased BNDF plasma levels were observed in psoriasis patients (P=0.01) (estimated marginal means of 3922 pg/mL; 95%CI=2660-5135) compared with controls (5788 pg/mL; 95%CI=5185-6442). …”
-
177
-
178
-
179
-
180
Supplementary Material for: Cardiac Troponin Is Elevated in Patients with Thyrotoxicosis and Decreases as Thyroid Function Improves and Brain Natriuretic Peptide Levels Decrease
Published 2020“…<b><i>Conclusions:</i></b> In thyrotoxicosis, the myocardial biomarker hsTnI is elevated in about 20% of patients; hsTnI levels decrease as thyroid function improves and BNP decreases.…”